Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
27/09/2023 13:06
Sept 27 (Reuters) - Harmony Biosciences Holdings Inc
HRMY.O :
* HARMONY BIOSCIENCES ANNOUNCES EXTENSION OF TENDER OFFER TO
ACQUIRE ZYNERBA PHARMACEUTICALS, INC.
* HARMONY BIOSCIENCES - TENDER OFFER WAS PREVIOUSLY
SCHEDULED TO
EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON TUESDAY, SEPTEMBER
26, 2023
* HARMONY BIOSCIENCES-EXTENDED EXPIRATION OF TENDER OFFER TO
ACQUIRE ALL OUTSTANDING SHARES OF COMMON STOCK OF ZYNERBA
PHARMACEUTICALS TO OCT 10, 2023
Source text for Eikon: ID:nPn2gybbGa
Further company coverage: HRMY.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zynerba Pharmaceuticals
See all newsBrief: Harmony Biosciences Completes Acquisition Of Zynerba Pharmaceuticals
Brief: Harmony Biosciences Announces Extension Of Tender Offer To Acquire Zynerba Pharmaceuticals, Inc.
Brief: Zynerba Pharmaceuticals Presents Positive Data From Phase 2 Inspire Trial
U.S. RESEARCH ROUNDUP-Easterly Government Properties, Visa, Zynerba Pharmaceuticals
Zynerba Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary